Elevated EVL methylation level in the normal colon mucosa is a potential risk biomarker for developing recurrent adenomas.

Ming Yu Kelly T Carter Kelsey K Baker Mary W Redman Ting Wang Kathy Vickers Christopher I Li Stacey A Cohen Mukta Krane Jennifer Ose Biljana Gigic Jane C Figueiredo Adetunji T Toriola Erin M Siegel David Shibata Martin Schneider Cornelia M Ulrich Lynda Ann Dzubinski Robert E Schoen William M Grady

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)

These findings support the potential utility of EVL methylation for improving the accuracy for assigning risk for recurrent colorectal adenomas and cancer.

Keyphrases

dna methylation
genome wide
papillary thyroid
human health
risk assessment
climate change
young adults
childhood cancer